Serum NT-proBNP levels and histopathological myocardial fibrosis in autopsied cases from a Japanese community: The Hisayama Study-Reference-Cited by-同舟云学术

Serum NT-proBNP levels and histopathological myocardial fibrosis in autopsied cases from a Japanese community: The Hisayama Study

Published:2021-09 Issue:3 Volume:78 Page:237-243
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Sasaki Takaya,Izumaru Kensuke,Hata Jun,Sakata Satoko,Oishi Emi,Nagata Takuya,Tsuboi Nobuo,Oda Yoshinao,Kitazono Takanari,Yokoo Takashi,Ninomiya Toshiharu

Funder

Government of Japan Ministry of Health Labour and Welfare

Japan Agency for Medical Research and Development

Government of Japan Ministry of Education Culture Sports Science and Technology

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference49 articles.

1. Towards better definition, quantification and treatment of fibrosis in heart failure: a scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology;de Boer;Eur J Heart Fail,2019

2. The pathogenesis of cardiac fibrosis;Kong;Cell Mol Life Sci,2014

3. Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential;Heymans;Eur J Heart Fail,2015

4. Mechanisms of fibrosis: therapeutic translation for fibrotic disease;Wynn;Nat Med,2012

5. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community;Ho;J Am Coll Cardiol,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Uric Acid Levels and Nephrosclerosis in a Population-Based Autopsy Study: The Hisayama Study;American Journal of Nephrology;2022